Q: Can BAC levels be measured by a breathalyzer test
For 5-Amino-1MQ to be considered for human use, it would require extensive preclinical safety testing followed by multiple phases of human trials a process typically led by pharmaceutical developers, none of whom have publicly committed to it
The safety profile is generally favorable, with most side effects being GI-related (nausea, constipation, diarrhea) that improve with time and gradual dose escalation
In a study spanning 16 weeks and including 172 male participants, the following side effects were observed following at least 16 doses (limited to one per day and a maximum of eight per month) [6]: Nausea: 12.8% Facial Flushing: 10.5% Increased Sweating: 9.3% Taste Disturbances: 4.7% These effects, particularly changes in taste, are common with peptide nasal sprays and are associated with the method of delivery
Comstock SS, Xu D, Hortos K, Kovan B, McCaskey S, Pathak DR, et al